Australia markets open in 5 hours 51 minutes

Navidea Biopharmaceuticals, Inc. (NO1A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.06650.0000 (0.00%)
As of 09:33AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts1111
Avg. Estimate-0.110.14-0.16-0.53
Low estimate-0.110.14-0.16-0.53
High estimate-0.110.14-0.16-0.53
Year ago EPS-0.13-0.11-0.48-0.16
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts1111
Avg. EstimateN/A9M9.38MN/A
Low estimateN/A9M9.38MN/A
High estimateN/A9M9.38MN/A
Year ago sales268k219k915k9.38M
Sales growth (year/est)N/A4,009.60%925.10%N/A
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.09-0.12-0.08-0.08
Actual EPS-0.13-0.11-0.11-0.09
Difference-0.040.01-0.03-0.01
Surprise %-44.40%8.30%-37.50%-12.50%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.110.14-0.16-0.53
7 days ago-0.090.03-0.24-0.39
30 days ago-0.090.03-0.24-0.39
60 days ago-0.08-0.08-0.3-0.4
90 days ago-0.08-0.08-0.3-0.4
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNO1A.FIndustrySector(s)S&P 500
Current qtr.15.40%N/AN/AN/A
Next qtr.227.30%N/AN/AN/A
Current year66.70%N/AN/AN/A
Next year-231.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A